EFAVIRENZ - Food and Drug Administration
- Manufacturer
- Food and Drug Administration
- Effective date
- 2020-10-07
- Label type
- Indexing - product concept
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-05 00:19:17
Label at a glance#
ProductEFAVIRENZ
Active ingredientEFAVIRENZ, LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE
Products#
Every source-derived product name is available through these pages.
- EFAVIRENZ
- LAMIVUDINE
- TENOFOVIR DISOPROXIL FUMARATE
- TENOFOVIR ANHYDROUS
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| EFAVIRENZ | JE6H2O27P8 | ACTIB |
| LAMIVUDINE | 2T8Q726O95 | ACTIB |
| TENOFOVIR DISOPROXIL FUMARATE | OTT9J7900I | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Efavirenz | EFAVIRENZ | Macleods Pharmaceuticals Limited | 13ca3456-e5bf-4bb1-af95-b1378658a358 | 2024-06-28 | Warnings, Adverse reactions | Efavirenz EFAVIRENZ |
| Efavirenz | EFAVIRENZ | Cipla USA Inc. | 92603fa5-7a2c-4bfb-9a70-aadb4fba952c | 2024-03-31 | Warnings, Adverse reactions | Efavirenz EFAVIRENZ |
| Efavirenz | EFAVIRENZ | Aurobindo Pharma Limited | 4c57ad7f-321a-46c8-851a-c895466eb8e1 | 2023-12-29 | Warnings, Adverse reactions | Efavirenz EFAVIRENZ |
| Efavirenz | EFAVIRENZ | Aurobindo Pharma Limited | c5eedb5d-4cab-4056-a14a-ffdf67701355 | 2023-12-29 | Warnings, Adverse reactions | Efavirenz EFAVIRENZ |
| Efavirenz | EFAVIRENZ | Camber Pharmaceuticals, Inc. | 6d625901-fef2-4c93-9619-f8991d65413d | 2023-05-15 | Warnings, Adverse reactions | Efavirenz EFAVIRENZ |
| EFAVIRENZ | EFAVIRENZ | XLCare Pharmaceuticals Inc. | 966b815d-1d78-4b54-8f00-c5a0b67c78be | 2023-01-12 | Warnings, Adverse reactions | EFAVIRENZ EFAVIRENZ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.